Janssen reports positive Risperdal depot data

Janssen (Beerse, Belgium), a subsidiary of Johnson & Johnson (JNJ), said that in a study of 400 schizophrenia patients, Risperdal depot risperdone gave a significant improvement on the primary end poi...